The authors identified AXL overexpression as an essential mechanism of trastuzumab resistance.
[Science Advances]
Home Newsletters Mammary Cell News Targeting HER2-AXL Heterodimerization to Overcome Resistance to HER2 Blockade in Breast Cancer
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
Brought to you by
